Dermatitis, Atopic

20 competing products in clinical development for Dermatitis, Atopic.

Pipeline by Phase

Phase 11

Phase 26

Phase 36

Approved7

Product	Company	Stage	Status	Hype
tacrolimus 0.1% + fluticasone 0.005 %	Astellas Pharma	Approved	Completed	43
tacrolimus ointment + pimecrolimus cream	Astellas Pharma	Approved	Completed	43
tacrolimus ointment + pimecrolimus cream	Astellas Pharma	Approved	Completed	43
Tacrolimus 0.03% + Fluticasone 0.005%	Astellas Pharma	Approved	Completed	43
Protopic + Corticosteroid + placebo	Astellas Pharma	Approved	Completed	43
Locobase® REPAIR	Astellas Pharma	Approved	Completed	43
tacrolimus ointment + pimecrolimus cream	Astellas Pharma	Approved	Completed	43
tacrolimus ointment	Astellas Pharma	Phase 3	Completed	40
tacrolimus ointment	Astellas Pharma	Phase 3	Completed	40
tacrolimus ointment	Astellas Pharma	Phase 3	Completed	40
tacrolimus ointment + Placebo ointment	Astellas Pharma	Phase 3	Completed	40
Tacrolimus ointment 0.1%	Astellas Pharma	Phase 3	Completed	40
tacrolimus ointment + Placebo ointment	Astellas Pharma	Phase 3	Completed	40
Tacrolimus Ointment 0.03% + Tacrolimus Ointment 0.03%	Astellas Pharma	Phase 2	Completed	35
Tacrolimus Ointment 0.1%	Astellas Pharma	Phase 2	Completed	35
Tacrolimus Ointment 0.03%	Astellas Pharma	Phase 2	Completed	35
Placebo + SCD-044_Dose 1 + SCD-044_Dose 2 + SCD-044_Dose 3	Sun Pharmaceutical	Phase 2	Completed	35
DSXS	Sun Pharmaceutical	Phase 2	Completed	35
KHK4083	Kyowa Kirin	Phase 1	Completed	29
ASN008	Formation Bio	Phase 2	Completed	25